F.D.A. Turmoil Keeps Spotlight on Its Commissioner
The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership of Dr. Marty Makary.
from NYT > Health https://ift.tt/62lPboe
via IFTTT
from NYT > Health https://ift.tt/62lPboe
via IFTTT

No comments